Skip to content
GenoLensGenoLens

C2

Chr 6p21.33

complement C2

MANE:
ENST00000299367.10

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • COVID-19 research

    BIALLELIC, autosomal or pseudoautosomal
  • Primary immunodeficiency or monogenic inflammatory bowel disease

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Ectodermal dysplasia

  • Familial cicatricial alopecia

  • Retinal disorders

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • Immunodeficiency due to a complement cascade protein anomaly

    0.71
  • immunodeficiency due to a classical component pathway complement deficiency

    0.60
  • systemic lupus erythematosus

    0.39
  • complement deficiency

    0.37
  • type 1 diabetes mellitus

    0.32
  • age-related macular degeneration

    0.19
  • macular degeneration

    0.12
  • retinal disorder

    0.12
  • lacrimal apparatus disorder

    0.09
  • Eyelid malformation

    0.09

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Complement C2

Precursor of the catalytic component of the C3 and C5 convertase complexes, which are part of the complement pathway, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12878586, PubMed:17027507, PubMed:18204047, PubMed:39914456, PubMed:39814882). Component C2 is part of the classical, lectin and GZMK complement systems (PubMed:12878586, PubMed:17027507, PubMed:18204047, PubMed:22691502, PubMed:39914456)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.